vaccine
Pharmaceutical company GlaxoSmithKline has been awarded a $342M contract by the U.S. Army to obtain COVID-19 vaccines in mass quantities from multiple vendors.
The service branch obligated the full contract amount at the time of award to support coronavirus response efforts at military sites within and outside the continental U.S., the Department of Defense said Thursday.
Army Contracting Command received one bid for the procurement.
Contract work will take place at Research Triangle Park in North Carolina through Feb. 28, 2021.
Check Also
The State Department has approved a potential $126M foreign military sale of armed assault vessels, ancillary equipment and contractor support services to the Philippines. The possible FMS transaction includes 36 scout boats, 36 assault boats, 18 light support boats, 156 M240B machine guns and other equipment such as forward-looking infrared, thermal imaging and RF-7850 radio systems, the Defense Security Cooperation Agency said Thursday.
Bethesda, Md.-based private equity firm IMB Partners has invested in network security company Ashburn Consulting for an undisclosed amount to help grow the latter’s presence in the government information technology services market. IMB said Wednesday the deal builds on its investment in IT services provider e&e six years ago and begins a long-term partnership with Ashburn.
